Status:
RECRUITING
Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Chronic Disease
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The presence of a clinical pharmacist (for their pharmacological expertise) and a general practitioner (for their somatic expertise) in surgery departments would contribute to improve the management o...
Eligibility Criteria
Inclusion
- The patient (or their representative) has given his consent and signed the consent form.
- The patient is affiliated to a health insurance programme.
- The patient is at least 65 years old (≥) treated by at least (≥) five medications for at least (≥) 6 months
- The patient is available for a follow-up of 3 months.
- The patient is hospitalized in the surgery department.
- Patient with a Trivalle score greater than or equal to 2 (≥).
- Patient living in a nursing home or going back home after hospitalization.
Exclusion
- The subject is participating in another category I interventional study.
- The subject is in an exclusion period determined by another study.
- The subject is under safeguard of justice.
- It is not possible to give the patient (or his/her trusted-person) informed information.
- Palliative care
Key Trial Info
Start Date :
July 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
297 Patients enrolled
Trial Details
Trial ID
NCT03827031
Start Date
July 18 2022
End Date
July 1 2027
Last Update
August 20 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu de Grenoble
Grenoble, France, 38043
2
CHU de Montpellier
Montpellier, France
3
Nimes University Hospital
Nîmes, France, 30029
4
CHU de Toulouse
Toulouse, France